GlobalData on MSN
Lynx Dx launches MPS2 prostate cancer test for at-home collection
Lynx Dx has commercially launched MyProstateScore 2.0 (MPS2), a urine test kit for prostate cancer intended for at-home ...
"Lynx Dx is proud to offer a solution that provides men with a more convenient, accessible, and accurate option for prostate cancer screening," said Dr. Spencer Heaton, Chief Medical Officer at Lynx ...
Study finds MPS2 scores are highly reproducible across DRE and non-DRE urine samples alike. "This study reinforces the value of MPS2 as a non-invasive diagnostic tool that delivers consistent and ...
Prostate cancer is the most common cancer and the second leading cause of cancer death in American men, affecting nearly one in eight. The prostate specific antigen (PSA) blood test has long been ...
ANN ARBOR, Mich., Nov. 18, 2024 /PRNewswire/ -- Lynx Dx, a leader in advanced diagnostic solutions for prostate cancer, is proud to announce that MyProstateScore 2.0 (MPS2) has been approved for ...
ANN ARBOR, Mich., Feb. 03, 2025 /PRNewswire/ -- Lynx Dx, a leader in innovative diagnostic solutions, announced today that its pioneering MyProstateScore 2.0 (MPS2) will be made available for at-home ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results